Related Experiment Video
Updated: Jan 24, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysis
1Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Adding immune checkpoint inhibitors to chemotherapy does not significantly increase high-grade hematological or gastrointestinal toxicities, except for a higher risk of severe diarrhea. This finding is crucial for understanding combination cancer therapy safety profiles.
Area of Science:
- Oncology
- Clinical Pharmacology
- Evidence-Based Medicine
Background:
- Immune checkpoint inhibitors (ICIs) combined with chemotherapy represent a significant advancement in cancer treatment.
- Understanding the toxicity profiles of these combinations is essential for clinical decision-making and patient safety.
Purpose of the Study:
- To systematically evaluate and clarify the toxicity patterns of combining chemotherapy with immune checkpoint inhibitors.
- To assess the risk of specific high-grade adverse events associated with these combination regimens.
Main Methods:
- A meta-analysis of randomized controlled trials comparing chemotherapy with or without ICIs (pembrolizumab, nivolumab, atezolizumab, durvalumab, avelumab).
- Relative risk (RR) was used as the primary summary statistic to compare toxicity rates.
- Eleven eligible studies were included in the final analysis.
Main Results:
- No significant increase in high-grade anemia (RR 0.98), thrombocytopenia (RR 1.10), or neutropenia (RR 0.96) was observed.
- High-grade nausea (RR 1.19) and vomiting (RR 1.09) showed no significant increase.
- A significant increase in high-grade diarrhea was noted (RR 2.61, p=0.002).
Conclusions:
- The addition of ICIs to chemotherapy does not generally elevate the risk of severe hematological toxicities.
- Most gastrointestinal toxicities, apart from diarrhea, are not significantly increased by ICI combination therapy.
- Clinicians should be particularly vigilant for and manage high-grade diarrhea when using chemotherapy and ICI combinations.
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Directing Effect of Substituents: meta-Directing Groups
What is the Immune System?
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Fixed Action Patterns

